Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06051721 · ClinicalTrials.gov registry record · Phase 2

A Study of a N, N-dimethyltryptamine (DMT) Analog (CYB004) in Participants With Generalized Anxiety Disorder (GAD)

A Phase 2 study of Generalized Anxiety Disorder, sponsored by Cybin IRL Limited.

Active
Registry status
Phase 2
Development phase
36
Enrollment target
6
Study locations

NCT06051721 is a Phase 2 study of Generalized Anxiety Disorder that is active but no longer recruiting, run by Cybin IRL Limited. The registered enrollment target is 36 participants, below the 214-participant average among 48 other Generalized Anxiety Disorder trials with a reported enrollment target (83% lower). The trial reports 6 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06051721, a Phase 2 study of Generalized Anxiety Disorder, is active but no longer recruiting, sponsored by Cybin IRL Limited.

ACTIVE NOT RECRUITING
Registry status
Phase 2
Development phase
36 participants
Enrollment target
6
Study locations

Study Summary

The purpose of this proof-of-concept trial is to examine the safety, tolerability, and pharmacokinetics (PK), and preliminary clinical efficacy of CYB004 participants with GAD.

Conditions Studied

Generalized Anxiety Disorder

Interventions

  • BEHAVIORAL Psychotherapy
  • DRUG CYB004

Study Locations (6)

Florida

  • Research Centers of America - Hollywood
  • Innovative Clinical Research, Inc. - Miami Lakes

Georgia

  • CenExel ACMR - Atlanta
  • iResearch Atlanta - Decatur

Illinois

  • Uptown Research Institute - Chicago

Utah

  • Cedar Clinical Research - Murray

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2024-05-10
Est. Completion 2026-09
Phase Phase 2

Sponsor

Cybin IRL Limited

4 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06051721

The ClinicalTrials.gov registry entry for NCT06051721 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 214-participant average among 48 other Generalized Anxiety Disorder trials with a reported enrollment target (83% lower). The listed sponsor is Cybin IRL Limited, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Generalized Anxiety Disorder appearing as the primary indexed condition, and to 2 interventions - of which Psychotherapy is the first listed.

NCT06051721 reports 6 study locations spanning 4 distinct geographic areas - top geographies include Florida, Georgia, Illinois.

Frequently Asked Questions

What is clinical trial NCT06051721 about?

NCT06051721 is a clinical study titled "A Study of a N, N-dimethyltryptamine (DMT) Analog (CYB004) in Participants With Generalized Anxiety Disorder (GAD)". The purpose of this proof-of-concept trial is to examine the safety, tolerability, and pharmacokinetics (PK), and preliminary clinical efficacy of CYB004 participants with GAD.

What is the current status of trial NCT06051721?

This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 36 participants. The study started on 2024-05-10. Estimated completion is 2026-09.

What conditions does trial NCT06051721 study?

This clinical trial studies the following conditions: Generalized Anxiety Disorder.

What interventions are being tested in trial NCT06051721?

The interventions under investigation include: Psychotherapy (BEHAVIORAL), CYB004 (DRUG).

Who is sponsoring clinical trial NCT06051721?

This trial is sponsored by Cybin IRL Limited, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06051721 being conducted?

This trial has 6 study locations across Florida, Georgia, Illinois, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Generalized Anxiety Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Generalized Anxiety Disorder

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.